Hepatic Angiosarcoma Post-Renal Transplantation: A Case Report

Transplant Proc. 2022 Jul-Aug;54(6):1597-1600. doi: 10.1016/j.transproceed.2022.05.015. Epub 2022 Jul 20.

Abstract

Background: DNA damage and oncogenic viruses increase the risk of cancer post-kidney transplantation, including skin cancer, Kaposi's sarcoma, oral cancer, and non-Hodgkin lymphoma. Here we report an uncommon case of liver angiosarcoma that occurred 8 years after kidney transplantation. This study strictly complied with the Helsinki Congress and the Istanbul Declaration regarding donor source.

Case report: A 57-year-old female patient received a cadaver kidney transplantation 8 years ago. She followed a long-term regimen of tacrolimus, mycophenolate sodium, and everolimus, with good renal function. She received annual regular abdominal ultrasound examinations after kidney transplantation, which showed no findings. The patient suffered from several symptoms for approximately 2 weeks before a scheduled abdominal ultrasound: diarrhea, epigastric pain, abdominal fullness, tea-colored urine, and little stool passage. The abdominal computerized tomography showed multiple hepatic tumors in both the hepatic lobes with engorged vasculatures and mild hemoperitoneum. A liver biopsy revealed the histopathology of angiosarcoma. The patient suffered multiple organ failure within one month of treatment.

Conclusions: Various post-transplant malignancies are not uncommon after transplantation, warranting periodic screenings for any symptoms in these patients.

Publication types

  • Case Reports

MeSH terms

  • Everolimus
  • Female
  • Hemangiosarcoma* / etiology
  • Humans
  • Immunosuppressive Agents
  • Kidney Transplantation* / adverse effects
  • Liver Neoplasms* / etiology
  • Liver Neoplasms* / surgery
  • Middle Aged
  • Mycophenolic Acid
  • Tacrolimus
  • Tea

Substances

  • Immunosuppressive Agents
  • Tea
  • Everolimus
  • Mycophenolic Acid
  • Tacrolimus